Tumour microvessel endothelial cell KIT and stem cell factor expression in human solid tumours

Histopathology

Volumn 55, Issue 5, 2009, Pages 544-553

  Sihto, Harri ^a   Tynninen, Olli ^b   Halonen, Maija ^a   Puputti, Marjut ^a,c   Karjalainen Lindsberg, Marja Liisa ^b   Kukko, Heli ^b   Joensuu, Heikki ^a,d  

^a Laboratory of Molecular Oncology   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c Helsinki Biomedical Graduate School   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Clear cell renal cell carcinoma; Endothelial cell; Glioblastoma; KIT proto oncogene; Microvessel density; Necrosis; Stem cell factor

Indexed keywords

MESSENGER RNA; STEM CELL FACTOR;

ARTICLE; CLEAR CELL CARCINOMA; CONTROLLED STUDY; EMBRYONAL CARCINOMA; ENDOTHELIUM CELL; GLIOBLASTOMA; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MICROVASCULATURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOLID TUMOR; SURVIVAL; TERATOMA; TUMOR VASCULARIZATION;

ANTIGENS, CD31; BRAIN NEOPLASMS; ENDOTHELIAL CELLS; FEMALE; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KI-67 ANTIGEN; MALE; MICROVESSELS; NEOPLASMS; STEM CELL FACTOR; TUMOR MARKERS, BIOLOGICAL;

EID: 71049157544     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2009.03418.x     Document Type: Article

References (27)

1. Yarden Y, Kuang WJ, Yang-Feng T et al. Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J. 1987 6 3341 3351.
2. Fleichman RA. From white spots to stem cells: the role of Kit receptor in mammalian development. Trends Genet. 1993 8 285 290.
3. Ogawa M, Nishikawa S, Yoshinaga K et al. Expression and function of c-Kit in fetal hemopoietic progenitor cells: transition from the early c-Kit-independent to the late c-Kit-dependent wave of hemopoiesis in the murine embryo. Development 1993 117 1089 1098.
4. Kissel H, Timokhina I, Hardy MP et al. Point mutation in Kit receptor tyrosine kinase reveals essential roles for Kit signaling in spermatogenesis and oogenesis without affecting other Kit responses. EMBO J. 2000 6 1312 1326.
5. Maeda H, Yamagata A, Nishikawa S et al. Requirement of c-kit for development of intestinal pacemaker system. Development 1992 116 369 375.
6. Hirata T, Morii E, Morimoto M et al. Stem cell factor induces outgrowth of c-kit-positive neurites and supports the survival of c-kit-positive neurons in dorsal root ganglia of mouse embryos. Development 1993 119 49 56.
7. Katafuchi T, Li AJ, Hirota S, Kitamura Y, Hori T. Impairment of spatial learning and hippocampal synaptic potentiation in c-kit mutant rats. Learn. Mem. 2000 7 383 392.
8. Sihto H, Sarlomo-Rikala M, Tynninen O et al. KIT and platelet-derived growth factor receptor alpha tyrosine kinase gene mutations and KIT amplifications in human solid tumors. J. Clin. Oncol. 2005 23 49 57. (Pubitemid 41702622)
9. Tian Q, Frierson HF Jr., Krystal GW, Moskaluk CA. Activating c-kit gene mutations in human germ cell tumors. Am. J. Pathol. 1999 154 1643 1647.
10. Krystal GW, Hines SJ, Organ CP. Autocrine growth of small cell lung cancer mediated by coexpression of c-kit and stem cell factor. Cancer Res. 1996 56 370 376.
11. Puputti M, Tynninen O, Sihto H et al. Amplification of KIT, PDGFRA, VEGFR2, and EGFR in gliomas. Mol. Cancer Res. 2006 4 927 934.
12. Matsui J, Wakabayashi T, Asada M, Yoshimatsu K, Okada M. Stem cell factorc-kit signaling promotes the survival, migration, and capillary tube formation of human umbilical vein endothelial cells. J. Biol. Chem. 2004 279 18600 18607.
13. Miettinen M, Sarlomo-Rikala M, Lasota J. KIT expression in angiosarcomas and fetal endothelial cells: lack of mutations of exon 11 and exon 17 of C-kit. Mod. Pathol. 2000 13 536 541.
14. Moses AV, Jarvis MA, Raggo C et al. Kaposi's sarcoma-associated herpesvirus-induced upregulation of the c-kit proto-oncogene, as identified by gene expression profiling, is essential for the transformation of endothelial cells. J. Virol. 2002 76 8383 8399.
15. Sun L, Hui AM, Su Q et al. Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. Cancer Cell 2006 9 287 300.
16. Litz J, Krystal GW. Imatinib inhibits c-Kit-induced hypoxia-inducible factor-1alpha activity and vascular endothelial growth factor expression in small cell lung cancer cells. Mol. Cancer Ther. 2006 5 1415 1422.
17. Han ZB, Ren H, Zhao H et al. Hypoxia-inducible factor (HIF)-1alpha directly enhances the transcriptional activity of stem cell factor (SCF) in response to hypoxia and epidermal growth factor (EGF). Carcinogenesis 2008 29 1853 1861.
18. Sihto H, Tynninen O, Bützow R, Saarialho-Kere U, Joensuu H. Endothelial cell KIT expression in human tumours. J. Pathol. 2007 211 481 488.
19. Gaudin PB, Rosai J. Florid vascular proliferation associated with neural and neuroendocrine neoplasms. A diagnostic clue and potential pitfall. Am. J. Surg. Pathol. 1995 19 642 652.
20. Straume O, Chappuis PO, Salvesen HB et al. Prognostic importance of glomeruloid microvascular proliferation indicates an aggressive angiogenic phenotype in human cancers. Cancer Res. 2002 62 6808 6811.
21. Théou-Anton N, Tabone S, Brouty-Boyé D et al. Co expression of SCF and KIT in gastrointestinal stromal tumours (GISTs) suggests an autocrineparacrine mechanism. Br. J. Cancer 2006 94 1180 1185.
22. Parikka M, Kainulainen T, Tasanen K, Bruckner-Tuderman L, Salo T. Altered expression of collagen XVII in ameloblastomas and basal cell carcinomas. J. Oral Pathol. 2001 30 589 595.
23. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N. Engl. J. Med. 1991 324 1 8.
24. Sun L, Lee J, Fine HA. Neuronally expressed stem cell factor induces neural stem cell migration to areas of brain injury. J. Clin. Invest. 2004 113 1364 1367.
25. Jögi A, Vallon-Christersson J, Holmquist L, Axelson H, Borg A, Phlman S. Human neuroblastoma cells exposed to hypoxia: induction of genes associated with growth, survival, and aggressive behavior. Exp. Cell Res. 2004 295 469 487.
26. Motzer RJ, Rini BI, Bukowski RM et al. Sunitinib in patients with metastatic renal cell carcinoma. JAMA 2006 295 2516 2524.
27. Escudier B, Eisen T, Stadler WM et al. Sorafenib in advanced clear-cell renal-cell carcinoma. N. Engl. J. Med. 2007 356 125 134.